Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas
Completed · Phase 2
Conditions studied: Pancreatic Cancer
In brief
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Gemcitabine may make tumor cells more sensitive to radiation therapy. Combining chemotherapy with radiation therapy after surgery may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine with radiation therapy in treating patients who have undergone surgery to remove cancer of the pancreas.
Key facts
- Study ID
- NCT00010166
- Run by
- Wake Forest University Health Sciences
- People needed
- 26
- Starts
- 2000-12-01
- Expected to finish
- 2003-10-03
- Last updated by the study team
- 2021-09-09
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Comprehensive Cancer Center at Wake Forest University — Winston-Salem, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.